Showing 1 - 10 of 13,189
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Persistent link: https://www.econbiz.de/10010417576
Persistent link: https://www.econbiz.de/10012439514
Intellectual property rights are viewed as essential to medical innovation, but very often involve social costs due to … patent monopolies and other inefficiencies. We review the positive theory of innovation in health care, as it relates to the … determination of innovation demand and supply. The positive theory is related to a host of competing normative models of …
Persistent link: https://www.econbiz.de/10014025575
This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …
Persistent link: https://www.econbiz.de/10011509446
the functioning of the patent system, innovation researchers have been surprisingly silent on the topic. This paper …
Persistent link: https://www.econbiz.de/10013278879
Persistent link: https://www.econbiz.de/10011925529
Persistent link: https://www.econbiz.de/10011498384
Persistent link: https://www.econbiz.de/10010249852
emanating from China's economic ascent could in theory either augment or stifle U.S. innovation. Using three decades of U ….S. patents matched to corporate owners, we quantify how foreign competition affects domestic innovation. Rising import exposure …
Persistent link: https://www.econbiz.de/10012105572